Selected vitamins and minerals in diabetes

Diabetes Care

Volumn 17, Issue 5, 1994, Pages 464-479

  Mooradian, Arshag D ^a   Failla, Mark ^b   Hoogwerf, Byron ^c   Maryniuk, Melinda ^d   Wylie Rosett, Judith ^e  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e Albert Einstein   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHROMIUM; COPPER; CYANOCOBALAMIN; FOLIC ACID; IRON; MAGNESIUM; MANGANESE; NICOTINIC ACID; PYRIDOXINE; RETINOL; SELENIUM; THIAMINE; TRACE ELEMENT; VITAMIN; VITAMIN D; ZINC;

CARBOHYDRATE TOLERANCE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; HUMAN; LEG ULCER; MINERAL DEFICIENCY; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; REVIEW; VITAMIN DEFICIENCY; WOUND HEALING;

EID: 0028280209     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.17.5.464     Document Type: Review

References (201)

1. Mooradian AD, Morley JE: Micronutrient status in diabetes mellitus. Am J Clin Nutr 45:877-895, 1987
2. Jenkins DJA: Dietary fibre, diabetes and hyperlipidemia. Lancet 2:1287-1290, 1979
3. Anderson JW, Ferguson SK, Karounos D, O'Malley L, Selling B, Clen WJL: Mineral and vitamin status on high-fiber diets: long-term studies of diabetic patients. Diabetes Care 3:38-40, 1980
4. Reed LR, Mooradian AD: Nutritional status and dietary management of elderly diabetic patients. Clin Ger Med 6:883-901, 1990
5. Cousins RJ: Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 238-244, 1985
6. American Diabetes Association: Consensus Statement: Magnesium supplementation in the treatment of diabetes. Diabetes Care 15:1065-1067, 1992
7. Mertz W: Chromium occurrence and function in biological systems. Physiol Rev 49:163-239, 1969
8. Mertz W, Toepfer EW, Roginski EE, Polansky MM: Present knowledge of a role of chromium. Fed Proc 33:2275-2280, 1974
9. Mertz W: Chromium in human nutrition: a review. J Nutr 123:626-633, 1993
10. Wallach S: Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr 4:107-120, 1985
11. Yamamoto A, Wada O, Suzuki H: Purification and properties of biologically active chromium complex from bovine colostrum. J Nutr 118:39-45, 1988
12. Tuman RW, Doisy RJ: Metabolic effects of the glucose tolerance factor (GRF) in normal and genetically diabetic mice. Diabetes 26:820-826, 1977
13. Schroeder HA: Chromium deficiency in rats: a syndrome simulating diabetes mellitus with retarded growth. J Nutr 88: 439-445, 1966
14. Wolliscroft J, Barbosa J: Analysis of chromium-induced carbohydrate intolerance in the rat. J Nutr 107:1702-1706, 1977
15. Jeejeeboy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531-538, 1977
16. Freund H, Atamian S, Fischer JE: Chromium deficiency during total parenteral nutrition. JAMA 241:496-498, 1979
17. Riales R, Albrink MJ: Effects of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoproteins of adult men. Am J Clin Nutr 34:2670-2678, 1981
18. Liu VJK, Morris JS: Relative chromium response as an indicator of chromium status. Am J Clin Nutr 31:972-976, 1978
19. Polansky MM, Anderson RA, Bryden NA, Roginski EE, Mertz W, Glinsmann WH: Chromium supplementation of free living subjects: effect on glucose tolerance and insulin (Abstract). Fed Proc 40:885, 1981
20. Polansky MM, Anderson RA, Bryden NA, Glinsmann WH: Chromium (Cr) and brewer's yeast supplementation of human subjects: effect on glucose tolerance, serum glucose, insulin, and lipid parameters (Abstract). Fed Proc 41:391, 1982
21. Glinsmann WH, Mertz W: Effect of trivalent chromium on glucose tolerance. Metab Clin Exp 15:510-520, 1966
22. Levine RA, Streeten DHP, Doisy RS: Effect of oral chromium supplementation on the glucose tolerance of elderly subjects. Metab Clin Exp 17:114-125, 1968
23. Offenbacker EG, Rinko CJ, Pi-Sunyer FX: The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects. Am J Clin Nutr 42:454-461, 1985
24. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann WH: Chromium supplementation of human subjects: effects on glucose insulin and lipid variables. Metabolism 32: 894-899, 1983
25. Anderson RA, Polansky MM, Bryden NA, Canary JJ: Supplemental chromium effects on glucose, insulin, glucagon and urinary chromium losses in subjects consuming low-chromium diets. Am J Clin Nutr 54:909-916, 1991
26. Urberg M, Parent M, Hill D, Zemel M: Evidence for synergism between chromium and nicotinic acid in normalizing glucose tolerance (Abstract). Diabetes 34 (Suppl. 1):147A, 1986
27. Sherman L, Glennon JA, Brech WJ, Klomberg GH, Gordon ES: Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism 17:439-442, 1968
28. Rabinowitz MB, Gonick HC, Levin SR, Davidson MB: Effect of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6:319-327, 1983
29. Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyorala KP, Koivistoinen PE, Lehto JT: Effect of inorganic chromium supplementation on glucose tolerance, insulin response and serum lipids in non-insulin-dependent diabetics. Am J Clin Nutr 38:404-410, 1983
30. Grant AP, McMullen JK: The effect of brewer's yeast containing glucose tolerance factor on the response to treatment in type II diabetics: a short controlled study. Ulster Med J 51:110-114, 1982
31. Hambidge KM, Rodgerson DO, O'Brien D: Concentration of chromium in the hair of normal children and children with juvenile diabetes mellitus. Diabetes 17:517-519, 1968
32. Rosson JW, Foster KJ, Walton RJ, Monro PP, Taylor TG, Alberti KGMM: Hair chromium concentrations in adult insulin-treated diabetics. Clin Chem Acta 93: 299-304, 1979
33. Rabinowitz MB, Levin SR, Gonick HC: Comparisons of chromium status in diabetic and normal men. Metabolism 29: 355-364, 1980
34. Earle KE, Archer AG, Baillie JE: Circulating and excreted levels of chromium, body mass index, hypoglycemic drugs, and presence and absence of diabetes mellitus. Am J Clin Nutr 49:685-689, 1989
35. Anderson RA, Bryden NA, Polansky MM, Reiser S: Urinary chromium excretion and insulinogenic properties of carbohydrates. Am J Clin Nutr 51:864-868, 1990
36. Quarterman J, Mills CF, Humphries WR: The reduced secretion of and sensitivity to insulin in zinc deficient rats. Biochem Biophys Res Commun 25:356-358, 1966
37. Hendricks DG, Mahoney AW: Glucose tolerance in zinc deficient rats. J Nutr 102:1079-1084, 1972
38. Huber AM, Gershoff SN: Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr 103:1739-1744, 1973
39. Kirchgessner M, Roth HP, Weigand E: Biochemical changes in zinc deficiency. In Trace Elements in Human Health and Disease: Zinc and Copper. Vol 1. Prasad AS, Oberleas D, Eds. New York, Academic Press, 1976, p. 189-266
40. Arquilla ER, Packer S, Tarmas W, Miyamoto S: The effect of zinc on insulin metabolism. Endocrinology 103:1440-1449, 1978
41. Coulston L, Dandona P: Insulin-like effect of zinc on adipocytes. Diabetes 29: 665-667, 1980
42. Ghalghazi T, Ludvigsen CW, McDaniel ML, Lacy PE: The inhibitory effect of zinc on insulin secretion. IRCS J Med Sci 7:122, 1979
43. Figlewicz DP, Formby B, Hodgson AT, Schmid FG, Grodsky GM: Kinetics of zinc uptake and distribution in fractions from cultured rat islets of Langerhans. Diabetes 29:767-773, 1979
44. Figlewicz DP, Heldt A, Forhan SE, Grodsky GM: Effect of exogenous zinc on insulin secretion in vivo. Endocrinology 108:730-732, 1980
45. Levine AS, McClain CJ, Handwerger BS, Brown DM, Morley JE: Tissue zinc status of genetically diabetic and streptozotocin-induced diabetic mice. Am J Clin Nutr 37:382-386, 1983
46. Kinlaw WB, Levine AS, Morley HE, Silvis SE, McClain CJ: Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273-277, 1983
47. Song MK, Mooradian AD: Intestinal zinc transport: influence of streptozotocin-induced diabetes, insulin and arachidonic acid. Life Sci 42:687-694, 1988
48. Walter RM Jr, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL: Cooper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 14:1050-1056, 1991
49. Pai LH, Prasad AS: Cellular zinc in patients with diabetes mellitus. Nutr Res 8:889-897, 1988
50. Mocchegiani E, Boemi M, Fumelli P, Fabris N: Zinc-dependent low thymic hormone level in type I diabetes. Diabetes 38:932-937, 1989
51. Nakamura T, Higashi A, Nishiyama S, Fujimoto S, Matsuda I: Kinetics of zinc status in children with IDDM. Diabetes Care 14:553-557, 1991
52. Niewoehner CB, Alien JI, Boosalis M, Levine AS, Morley JE: The role of zinc supplementation in type II diabetes mellitus. Am J Med 81:63-68, 1986
53. Mooradian AD, Norman DC, Morley JE: The effect of zinc status on the immune function of diabetic rats. Diabetologia 31: 703-707, 1988
54. Mooradian AD, Morley JE, Scarpace PJ: The role of zinc status in altered cardiac adenylate cyclase activity in diabetic rats. Acta Endocrinel 119:174-180, 1988
55. Uriu-Hare JY, Stern JS, Keen CL: Influence of maternal dietary Zn intake on expression of diabetes-induced teratogenicity in rats. Diabetes 38:1282-1290, 1989
56. Begin-Heick N, Dalpe-Scott M, Rowe J, Heick HMC: Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 34:179-184, 1985
57. Haeger K, Lanner E, Magnusson PO: Oral zinc sulfate in the treatment of venous leg ulcer. In Clinical Applications of Zinc Metabolism. Pories WJ, Strain WH, Hsu JM, Woosley RL, Eds. Springfield, IL, Thomas, 1974, p. 158-67
58. Hallbook T, Lanner E: Serum-zinc and healing of venous leg ulcers. Lancet 2:780-782, 1972
59. Hooper PL, Visconti L, Carry PJ, Johnson GE: Zinc lowers high-density lipoprotein cholesterol levels. JAMA 244: 1960-1961, 1980
60. Morley JE, Korenman SG, Mooradian AD, Kaiser FE: Male sexual dysfunction in the elderly. J Am Geriatr Soc 34:1014-1022, 1987
61. Cohen AM, Teitelbaum A, Miller E, BenTor V, Hirt R, Fields M: The effect of copper on carbohydrate metabolism. Isr J Med Sci 18:840-844, 1982
62. Noto R, Alicata R, Sfogliano L, Neris S, Bifarella M: A study of cupremia in a group of elderly diabetics. Acta Diabetol Lat 20:81-85, 1983
63. Lisun-Lobanova VP: Trace elements (manganese, copper, and zinc) in patients with diabetes mellitus. Zdravookhr Beloruss 9:49-54, 1963
64. Kanabrocki EL, Case LF, Graham L, Fields T, Miller EB, Dester YT, Kaplan E: Non-dialyzable manganese and copper levels in serum of patients with various diseases. J Nuel Med 8:166-172, 1967
65. Martin Mateo MC, Bustamante Bustamante J, Gonzalez Cantalapiedra MA: Serum zinc, copper, and insulin in diabetes mellitus. Biomedicine 29:56-58, 1978
66. Lahey ME, Gubler CJ, Cartwright GE, Wintrobe MM: Studies on copper metabolism. VI. Blood copper in normal human subjects. J Clin invest 32:322-328, 1953
67. Pidduck BS, Wren MD: Plasma zinc and copper in diabetes mellitus. Diabetes 19: 234-239, 1970
68. Failla ML, Kiser RA: Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J Nutr 111:1900-1909, 1981
69. Failla ML, Kiser RA: Hepatic and renal metabolism of copper and zinc in the diabetic rat. Am J Physiol 244:E115-E121, 1983
70. Johnson WT, Evans GW: Effects of the interrelationship between dietary protein and minerals on tissue content of trace metals in streptozotocin-diabetic rats. J Nutr 114:180-190, 1984
71. Carnes WH: Copper and connective tissue metabolism. Int Rev Connect Tissue Res 4:197-232, 1968
72. Schroeder HA: The role of trace elements in cardiovascular diseases. Med Clin North Am 58:381-396, 1974
73. Jarrett RJ, Keen H: Diabetes and atherosclerosis. In Complications of Diabetes. Jarrett RJ, Keen H, Eds. London, Arnold, 1975, p. 179-204
74. Klevay LM, Inman L, Johnson LK, Lawler M, Mahalko JR, Milne DB, Lukask HS, Bolenchek W, Sandsherd HH: Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 33:1112-1118, 1984
75. Sjogren A, Edvinsson L, Floren C-H, Abdulla M: Zinc and copper in straited muscle and body fluids from subjects with diabetes mellitus type I. Nutr Res 6:147-154, 1986
76. Craft NE, Failla ML: Zinc, iron, and copper absorption in the streptozotocindiabetic rat. Am J Physiol 244:E122-E128, 1983
77. Lau AL, Failla ML: Urinary excretion of zinc, copper and iron in the streptozotocin-diabetic rat. J Nutr 114:224-233, 1984
78. Lehninger AS: Role of metal ions in enzyme systems. Physiol Rev 30:393-429, 1950
79. Aikawa JK: Magnesium: Its Biologic Significance. Fort Lauderdale, CRC, 1981
80. Goldman J, Fisher V: Magnesium is required in addition to calcium for insulin stimulation of glucose transport (Abstract). Endocrinology 112 (Suppl.):271, 1983
81. Yajnik CS, Smith RF, Hockaday TDR, Ward NI: Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J 288:1032-1034, 1984
82. Fujii S, Takemura T, Wada M, Akai T, Okuda K: Magnesium levels in plasma, erythrocyte and urine in patients with diabetes mellitus. Harm Metab Res 14: 161-162, 1982
83. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol IB: Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 12:81-85, 1982
84. Butler AM: Diabetic coma. N Engl J Med 1243:648-659, 1950
85. Fort P, Lifshitz F, Wapnir IL, Wapnir RA: Magnesium metabolism in experimental diabetes mellitus. Diabetes 26: 882-886, 1977
86. Schneider LE, Schedl HP: Effects of alloxan diabetes on magnesium metabolism in the rat. Proc Soc Exp Biol Med 147: 494-497, 1974
87. Jain AP, Gupta NN, Kumar A: Some metabolic effects of magnesium in diabetes mellitus. J Assoc Physicians India 24: 827-831, 1976
88. Ewald U, Gebre-Medhin M, Tuvemo T: Hypomagnesemia in diabetic children. Acta Paediatr Scand 72:367-371, 1983
89. Rosner F, Gorfien PC: Zinc and magnesium levels in diabetes. JAMA 211:2156, 1970
90. Milewicz A, Stepien-Dobrowlska M, Szklarz E, Glebowska H, Gladysz A, Czarnowska J: Behaviour of the magnesium level in the serum, whole blood and erythrocytes in juvenile diabetes. Wiad Lek 29:599-601, 1976
91. Levine GE, Mather HM, Pilkington TRE: Tissue magnesium status in diabetes mellitus. Diabetologia 21:131-134, 1981
92. DeLeeuw I, Vertommen J, Abs R: The magnesium content of the trabecular bone in diabetic subjects. Biomedicine 29:16-17, 1978
93. Sjogren A, Floren CH, Nilsson A: Magnesium, potassium, and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224:461-466, 1988
94. Paolisso G, Passariello N, Pizza G, Marrazzo G, Giunta R, Sgambato S, Varricchio M, D'Onofrio F: Dietary magnesium supplements improve β-cell response to glucose and arginine in elderly non-insulin-dependent diabetic subjects. Acta Endocrinol 121:16-20, 1989
95. McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbøl I: Hypomagnesaemia, a risk factor in diabetic retinopathy. Diabetes 27:1075-1077, 1978
96. Seelig MS, Heggtveit HA: Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr 27:59-79, 1974
97. Marier JR: Cardio-protective contribution of hard waters to magnesium intake. Rev Can Biol 37:115-125, 1978
98. American Diabetes Association: Magnesium supplementation in the treatment of diabetes. Diabetes Care 16: (Suppl. 2): 79-81, 1993
99. Everson GJ, Shrader RE: Abnormal glucose tolerance in manganese deficient guinea pigs. J Nutr 94:89-94, 1968
100. Bond JS, Failla ML, Unger DF: Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. J Biol Chem 258: 8004-8009, 1983
101. Eriksson UJ: Diabetes in pregnancy: retarded fetal growth, congenital malformations, and feto maternal concentrations of zinc, copper, and manganese in the rat. J Nutr 114:447-484, 1984
102. Walter RM, Aoki T, Keen CL: Acute oral manganese does not consistently affect glucose tolerance in nondiabetic and type II diabetic humans. J Trace El Exp Med 4:73-79, 1991
103. Rubenstein AH, Levin NW, Elliott GA: Manganese-induced hypoglycemia. Lancet 2:1348-1351, 1962
104. Hegde B, Griffith GC, Butt EM: Tissue and serum manganese levels in evaluation of heart muscle damage: a comparison with SGOT. Proc Soc Exp Biol Med 107:734-737, 1961
105. Volkov NF: Cobalt, manganese, and zinc content in the blood of atherosclerosis patients. Fed Proc 22:897-899, 1963
106. Cutler P: Deferoxamine therapy in high ferritin diabetes. Diabetes 38:1207-1210, 1989
107. Redman JB, Pyzdrowski KL, Robertson P: No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes 42:544-549, 1993
108. Dandona P, Hussain MA, Varghese Z, Politis D, Flynn DM, Hoffbrand AV: Insulin resistance and iron overload. Ann Clin Biochem 20:77-79, 1983
109. Bern MM, Busick EJ: Disorders of blood and diabetes. In Joslin's Diabetes Mellitus. Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS, Eds. Philadelphia, PA, Lea and Febiger, 1985, p. 748-752
110. Asayama K, Kooy NW, Burr IM: Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 107:459-464, 1986
111. Sunde RA, Hoekstra WG: Structure, synthesis and functions of glutathione peroxidase. Nutr Rev 38:265-273, 1980
112. Van Rij AM, Thomson CD, McKenzie JM, Robinson MF: Selenium deficiency in total parenteral nutrition. Am J Clin Nutr 32:2076-2085, 1979
113. Chen X, Yang G, Chen J, Chen X, Wen Z, Ge K: Studies on the relations of selenium and Keshan disease. Biol Trace Elem Res 2:91-107, 1980
114. Johnson RA, Baker SS, Fallen JT, Maynard EP, Ruskm JN, Wen Z, Ge K, Cohen HJ: An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med 304:1210-1212, 1981
115. Gebre-Medhin M, Ewald V, Plantin LO, Tuvemo T: Elevated serum selenium in diabetic children. Acta Paediatr Scand 73:109-114, 1984
116. Strain JJ: Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 50:591-604, 1991
117. Chertow BS, Baker GR: The effects of vitamin A on insulin release and glucose oxidation in isolated rat islets. Endocrinology 103:1562-1572, 1979
118. Seifter E, Readawer J, Stratford F, Kambosos D, Levenson SM: Impaired wound healing in streptozotocin diabetes: prevention by supplemental vitamin A. Ann Surg 194:42-50, 1981
119. Ramachandran K: Beta caro levels in diabetes mellitus. J Pharmacol 31:1098-1100, 1981
120. Basu TK, Tze WJ, Leichter J: Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr 50:329-333, 1989
121. Saito N, Kimura M, Kuchiba A, Itokawa Y: Blood thiamine levels in outpatients with diabetes mellitus. J Nutr Sci Vitaminol 33:421-430, 1987
122. Hobara R, Ozawa K, Okazaki M, Yasuhara H: Relationship between thiamine and glucose levels in diabetes mellitus. J Pharmacol 31:1098-1100, 1981
123. Kjosen MS, Seim SH: The transketolase assay of thiamine in some diseases. Am J Clin Nutr 30:1591-1596, 1977
124. Vague P, Picq R, Bernal M, Lassmann-Vague V, Vialettes B: Effect of nicotinamide treatment on the residual insulin secretion in type I (insulin-dependent) diabetic patients. Diabetologia 32:316-321, 1989
125. Mendola G, Casamitjana R, Gomis R: Effect of nicotinamide therapy upon β-cell function in newly diagnosed type I (insulin-dependent) diabetic patients. Diabetologia 32:160-162, 1989
126. Pozzilli P, Visalli N, Ghirlanda G, Manna R, Andreani D: Nicotinamide increases C-peptide secretion in patients with recent onset type I diabetes. Diabetic Med 6:568-572, 1989
127. Lewis CM, Canafax DM, Sprafka JM, Barbosa JJ: Double-blind randomized trial of nicotinamide on early-onset diabetes. Diabetes Care 15:121-123, 1992
128. Sebastian HM, de Castro Del Pozo S, De La Fuente, Gomez L, Caro-Paton Gomez T: Estudio sobre carencia de piridoximia en los diabeticos. Rev Clin Esp 91:99-103, 1963
129. Davis RE, Calder JS, Curhow DH: Serum pyridoxal and folate concentrations in diabetics. Pathology 8:151-159, 1976
130. Wilson RG, David RE: Serum pyridoxal concentrations in children with diabetes mellitus. Pathology 9:95-98, 1977
131. Toyota T, Kai Y, Kakizaki M, Ohtsuka H, Shibata Y, Goto Y: The endocrine pancreas in pyridoxine deficient rats. Tohuku J Exp Med 134:331-336, 1981
132. Tezuka I, Makino K: Hyperglycemia in pyridoxine deficient rats. J Vitaminol (Kyoto) 5:304-306, 1959
133. 6 upon diabetic and control rats. Vitam Horm 22:643-653, 1964
134. Quagliariello E, Papa S, Saccone C, Alifano A: Effect of 3-hydroxyanthranilic acid on the mitochondrial respiratory system. Biochem J 91:137-146, 1964
135. Veneziale CM, Walter P Kneer N, Lardy HA: Influence of L-tryptophan and its metabolites on gluconeogenesis in the isolated perfused liver. Biochemistry 6:2129-2138, 1967
136. Kotake Y, Sotokawa T, Murakami E, Hisatake A, Abe M, Ideka Y: Studies on the xanthurenic acid-insulin complex. II. Physiological activities. J Biochem (Tokyo) 63:578-581, 1968
137. 6), and tryptophan on carbohydrate metabolism. Lancet 1:759-764, 1976
138. Perkins RP: Failure of pyridoxine to improve glucose tolerance in gestational diabetes mellitus. Obstet Gynecol 50: 370-372, 1977
139. Gillmer MDG, Mazibuku D: Pyridoxine treatment of chemical diabetes in pregnancy. Am J Obstet Gynecol 133:499-502, 1979
140. Rao RH, Vigg BL, Jaya Rao KS: Failure of pyridoxine to improve glucose tolerance in diabetics. J Clin Endocrinol Metab 50: 198-200, 1980
141. 6 therapy in type II diabetes mellitus. Diabetes 38:881-886, 1989
142. Kaplan WE, Abourizk NN: Diabetic peripheral neuropathies affecting the lower extremity. J Am Podiatry Assoc 71:356-362, 1981
143. Schamberg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ: Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med 309:445-448, 1983
144. Trence DL, Morley JE, Handwerger BS: Polyglandular autoimmune syndromes. Am J Med 77:107-116, 1984
145. Reed RL, Mooradian AD: Nutritional status and dietary management of elderly diabetic patients. Clin Geriatr Med 6:883-901, 1990
146. Ide H, Fujiya S, Asanuma Y, Tsuji M, Sakai H, Agishi Y: Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clin Ther 9:183-192, 1987
147. Patterson JW: The diabetogenic effect of dehydroascorbic and dehydroisoascorbic acid. J Biol Chem 183:81-88, 1950
148. Sjostrand SE: Pharmacological properties of dehydroascorbic acid and ascorbic acid: effects on the central and peripheral nervous systems in experimental animals. Acta Physiol Scand 358 (Suppl.):1-79, 1970
149. Som S, Basu S, Mukherjee D, Deb S, Choudhury PR, Mukherjee S, Chatterjee SN, Chatterjee IB: Ascorbic acid metabolism in diabetes mellitus. Metabolism 30:572-577, 1981
150. Newill A, Habibzadeh N, Bishop N, Schorah CJ: Plasma levels of vitamin C components in normal and diabetic subjects. Ann Clin Biochem 21:488-490, 1984
151. Stankova L, Riddle M, Larned J, Burry K, Meneshe D, Hart J, Bigley R: Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 33: 347-353, 1984
152. Schorah CJ, Bishop N, Wales JK, Hansbro PM, Habibzadeh N: Blood vitamin C concentrations in patients with diabetes mellitus. Int J Vitam Nutr Res 58:312-318, 1988
153. Chen MS, Hutchinson ML, Pecoraro RE, Lee WYL, Labbe RF: Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 32:1078-1081, 1983
154. Mooradian AD: The effect of ascorbate and dehydroascorbate on tissue uptake of glucose. Diabetes 36:1001-1004, 1987
155. Yew MS: Effect of streptozotocin diabetes on tissue ascorbic acid and dehydroascorbic acid. Horm Metab Res 15: 158, 1983
156. Sarji KE, Kleinfelder J, Brewington P, Gonzalez J, Hempling H, Colwell JA: Decreased platelet vitamin C in diabetes mellitus: possible role in hyperaggregation. Thromb Res 15:639-650, 1979
157. Jennings PE, Chirico S, Jones AF, Lunec J, Barnett AH: Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res 6:151-154, 1987
158. Stankova L, Riddle M, Larned J, Burry K, Meneshe D, Hart J, Bigley R: Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 33: 347-353, 1984
159. Ginter E, Zdichynec B, Holzerova O, Ticha E, Kobza R, Koziakova M, Cerra O, Ozdin L, Hruba F, Novakova V, Sasko E, Gaber M: Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus. Int J Vitam Nutr Res 48:368-373, 1978
160. Cox BD, Butterfield WJH: Vitamin C supplements and diabetic cutaneous capillary fragility. Br Med J 3:205, 1975
161. Bishop N, Schorah CJ, Wales JK: The effect of vitamin C supplementation on diabetic hyperlipidemia: a double blind, crossover study. Diabetic Med 2:121-124, 1985
162. Vinson JA, Staratz ME, Bose P, Kassm HM, Basalyga BS: In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes 38:1036-1041, 1989
163. Yue DK, McLennan S. Fisher E, Heffernan S, Capogreco C, Ross GR, Turtle JR: Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 38:257-261, 1989
164. Som S, Basu S, Mukherjee D, Deb S, Choudhury PR, Mukherjee S, Chatterjee SN, Chatterjee IB: Ascorbic acid metabolism in diabetes mellitus. Metabolism 30:572-577, 1981
165. National Research Council (U.S.) Committee on Dietary Allowances: Recommended Dietary Allowances. 10th ed. Washington, D.C., National Academy Press, 1989
166. Alhadeff L, Guaitieri CT, Lipton M: Toxic effects of water-soluble vitamins. Nutr Rev 42:33-40, 1984
167. Darby WJ, Ferguson ME, Furman RH, Lemley JM, Ball CT, Meneely GR: Plasma tocopherols in health and disease. Ann NY Acad Sci 52:328-388, 1949
168. Vatassery GT, Morley HE, Kuskowski MA: Vitamin E in plasma and platelets of human diabetic patients and control subjects. Am J Clin Nutr 37:641-644, 1983
169. McMasters V, Howard T, Kinsell LW, Van Der Veen J, Olcott MS: Tocopherol storage and depletion in adipose tissue and plasma of normal and diabetic human subjects. Am J Clin Nutr 20:622-666, 1967
170. Caye-Vaugien C, Krempf M, Lamarche P, Charbonnel B, Peiri J: Determination of alpha-tocopherol in plasma, platelets, and erythrocytes of type I and type II diabetic patients by high-performance liquid chromatography. Int J Vitam Nutr Res 60:324-330, 1990
171. Gisinger C, Wantanabe J, Colwell JA: Vitamin E and platelet eicosanoids in diabetes mellitus. Prostaglandins Leukotrienes Essent Fatty Acids 40:169-179, 1990
172. Watanabe J, Umeda F, Wakasugi H, Ibayashi H: Effect of vitamin E on platelet aggregation in diabetes mellitus. Thromb Haemost 51:313-316, 1984
173. Karpen CW, Cataland S, O'Dorisio TM, Panganamala RV: Production of 12-hydroxy eicosatetraenoic acid and vitamin E status in platelets from type I human diabetic subjects. Diabetes 34: 526-531, 1985
174. Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P, Schemthaner G: Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients: double-blind crossover trial. Diabetes 37:1260-1264, 1988
175. Colette C, Pares-Herbute N, Monnier LH, Cartry E: Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E. Am J Clin Nutr 47:256-261, 1988
176. Kunisaki M, Umeda F, Inoguchi T, Wantanabe J, Nawata H: Effects of vitamin E administration on platelet function in diabetes mellitus. Diabetes Res 14:37-42, 1990
177. Wu HP, Tai TY, Chuang LM, Lin BJ, Wnag JD, Teng CM: Effect of tocopherol on platelet aggregation in non-insulin-dependent diabetes mellitus: ex vivo and in vitro studies. Taiwan I-Hsueh-Hui Tsa-Chih 91:270-275, 1992
178. Ozden I, Deniz G, Tasali E, Ulusarac A, Altug T, Buyukdevrim S: The effect of vitamin E on glycosylated hemoglobin levels in diabetic rats: a preliminary report. Diabetes Res 12:123-124, 1989
179. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ: Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications? Diabetes Care 14:68-72, 1991
180. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 57:650-656, 1993
181. Vandewoude MG, VanGaar LF, Vandewoude MF, De-Leeuw IH: Vitamin E status in normocholesterolemic and hyper-cholesterolemic diabetic patients. Acta Diabetol Lat 24:133-139, 1987
182. Krempf M, Rangnathan S, Ritz P, Morin M, Charbonnel B: Plasma vitamin A and E in type I (insulin-dependent) and type II (non-insulin-dependent) adult diabetic patients, Int J Vitam Nutr Res 61: 38-42, 1991
183. Morel DW, Chisolm GM: Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30:1827-1834, 1989
184. Rodland O, Markestad T, Aksnes L, Aarskog D: Plasma concentrations of vitamin D metabolites during puberty of diabetic children. Diabetologia 28:663-666, 1985
185. McNair P: Bone mineral metabolism in human type I (insulin dependent) diabetes mellitus. Dan Med Bull 32:109-121, 1988
186. Hui SL, Epstein S, Johnston CC Jr: A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 60:74-80, 1985
187. Leon M, Larrodera L, Lledo G, Hawkins F: Study of bone loss in diabetes mellitus type I. Diabetes Res Clin Pract 6:237-242, 1989
188. Verrotti A, Blasetti A, Tumini S, Chiarelli F, Morgese G: Calcium homeostasis in prepubertal diabetic children. Acta Diabetol Lat 25:173-177, 1988
189. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J: Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 37:8-12, 1988
190. Kuoppala T: Alterations in vitamin D metabolites in diabetic pregnancy. Gynecol Obstet Invest 25:99-105, 1988
191. Mimouni F, Tsang RC, Hertzberg VS, Neumann-V, Ellis K: Parathyroid hormone and calcitriol changes in normal and insulin-dependent diabetic pregnancies. Obstet Gynecol 74:49-51, 1989
192. Levin ME, Boisseau VC, Avioli LV: Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294:241-245, 1976
193. Weinstock RS, Goland RS, Shane E, Clemens TL, Lindsay R, Bilezikian JP: Bone mineral density in women with type II diabetes mellitus. J Bone Miner Res 4:97-101, 1989
194. Isaia-G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM: Osteoporosis in type II diabetes. Acta Diabetol Lat 24:305-310, 1987
195. Ishida H, Seino Y, Matsukura S, Ikeda M, Yawata M, Yamashita G: Diabetic osteopenia and circulating levels of vitamin D metabolites in type II (non-insulin-dependent) diabetes. Metabolism 34: 797-801, 1985
196. National Insitutes of Health Consensus Conference: Osteoporosis. JAMA 252: 799-802, 1984
197. 12 and folie acid serum levels in diabetics under various therapeutic regimens. Diabete Metab 2:187-192, 1976
198. Kaplan J, Hess JW, Prasad AS: Impaired interleukin-2 production in the elderly: association with mild zinc deficiency. J Trace Elem Exp Med 1:3-8, 1988
199. Prasad AS, Meflah S, Abdallah J, Daplan J, Brewer GJ, Back JF, Dardenne M: Serum thymulin in human zinc deficiency. J Clin Invest 82:1202-1210, 1988
200. Grider A, Bailey LB, Cousins RJ: Erythrocyte metallothionein as an index of zinc status in humans. Proc Pak Acad Sci 87:1259-1262, 1990
201. American Diabetes Association: Exchange Lists for Meal Planning. Alexandria, VA, American Diabetes Association, 1989